Insider · CIK 0001822879

Leonard Frank X

Reports to the SEC for 1 company · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001822879

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+1,905 sh	$11.15	+$21.2K	461,425
2026-06-04	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−34.3K sh	$17.93	−$615K	459,520
2026-03-04	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−5,607 sh	$13.31	−$74.6K	493,793
2026-03-03	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+150K sh	—	—	499,400
2026-03-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Chief Executive Officer	AAward	+216K sh	—	—	216,388
2026-03-02	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−7,232 sh	$13.49	−$97.6K	349,400
2026-02-28	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+18.6K sh	—	—	356,632
2026-02-27	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−9,734 sh	$13.66	−$133K	338,011
2025-11-01	NVCRNovoCure LtdF Tax Payment	Chief Executive Officer	FTax Payment	−966 sh	$12.81	−$12.4K	347,745
2025-06-30	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+833 sh	$15.13	+$12.6K	348,711
2025-06-04	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+179K sh	—	—	347,878
2025-06-02	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−21.7K sh	$17.22	−$374K	176,931
2025-06-02	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−6,600 sh	$17.99	−$119K	170,331
2025-06-02	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−1,879 sh	$19.01	−$35.7K	168,452
2025-03-04	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+55K sh	$18.19	+$1M	198,648
2025-03-04	NVCRNovoCure Ltd · Stock Options (Right to buy)A Award	Chief Executive Officer	AAward	+81.5K sh	$18.19	+$1.48M	81,499
2025-03-03	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−2,527 sh	$18.54	−$46.8K	143,673
2025-02-28	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−2,770 sh	$18.28	−$50.6K	146,200
2025-02-28	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−2,770 sh	$18.28	−$50.6K	146,200
2025-02-27	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−10.3K sh	$19.92	−$205K	150,959
2025-02-27	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−1,989 sh	$20.55	−$40.9K	148,970
2025-02-27	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−10.3K sh	$19.92	−$205K	150,959
2025-02-27	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−1,989 sh	$20.55	−$40.9K	148,970
2024-11-01	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−598 sh	$15.94	−$9,530.745	161,236
2024-06-28	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+1,736 sh	$12.24	+$21.2K	161,834
2024-03-04	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−840 sh	$16.01	−$13.4K	160,098
2024-03-01	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−1,679 sh	$16.03	−$26.9K	160,938
2024-02-28	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−2,078 sh	$16.14	−$33.5K	162,617
2024-02-27	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+102K sh	$16.30	+$1.67M	164,695
2024-02-27	NVCRNovoCure Ltd · Stock Options (Right to buy)A Award	Chief Executive Officer	AAward	+156K sh	$16.30	+$2.55M	156,348
2023-03-07	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−6,003 sh	$75.00	−$450K	56,599
2023-03-07	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−2,315 sh	$75.59	−$175K	54,284
2023-03-03	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−888 sh	$76.16	−$67.6K	62,602
2023-03-03	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+11.8K sh	—	—	69,952
2023-03-03	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−2,059 sh	$77.64	−$160K	67,893
2023-03-03	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−4,403 sh	$76.16	−$335K	63,490
2023-03-02	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−3,799 sh	$75.32	−$286K	59,296
2023-03-02	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−308 sh	$76.05	−$23.4K	58,988
2023-03-02	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−844 sh	$75.28	−$63.5K	58,144
2023-03-01	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−1,684 sh	$76.36	−$129K	63,095
2023-02-28	NVCRNovoCure LtdA Award	Chief Executive Officer	AAward	+18.6K sh	—	—	64,779
2023-02-28	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Chief Executive Officer	AAward	+31K sh	$76.97	+$2.38M	30,971
2023-01-05	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−2,345 sh	$119.01	−$279K	48,111
2023-01-05	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−417 sh	$108.00	−$45K	47,694
2023-01-05	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−526 sh	$115.03	−$60.5K	47,168
2023-01-05	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−1,010 sh	$117.00	−$118K	46,158
2023-01-05	NVCRNovoCure LtdM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+7,826 sh	$14.37	+$112K	53,984
2023-01-05	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−7,826 sh	$108.00	−$845K	46,158
2023-01-05	NVCRNovoCure LtdM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+7,500 sh	$11.46	+$86K	53,658
2023-01-05	NVCRNovoCure LtdS Sale	Chief Executive Officer	SSale	−7,500 sh	$108.00	−$810K	46,158

Recent filings

Accepted (ET)
Jul 14
Leonard Frank X0001822879-26-000006
SEC(opens sec.gov)
Jun 54
Leonard Frank X0001822879-26-000004
SEC(opens sec.gov)
Mar 54
Leonard Frank X0001822879-26-000003
SEC(opens sec.gov)
Mar 34
Leonard Frank X0001822879-26-000002
SEC(opens sec.gov)
Nov 44
Leonard Frank X0001822879-25-000006
SEC(opens sec.gov)
Jul 14
Leonard Frank X0001562180-25-005188
SEC(opens sec.gov)
Jun 64
Leonard Frank X0001562180-25-004553
SEC(opens sec.gov)
Jun 44
Leonard Frank X0001562180-25-004426
SEC(opens sec.gov)
Mar 64
Leonard Frank X0001562180-25-002159
SEC(opens sec.gov)
Mar 44
Leonard Frank X0001562180-25-001976
SEC(opens sec.gov)
Mar 34/A
Leonard Frank X0001562180-25-001915
SEC(opens sec.gov)
Mar 34
Leonard Frank X0001562180-25-001834
SEC(opens sec.gov)

Companies

NovoCure LtdChief Executive OfficerNVCR

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087